Post de CIUSSS du Centre-Ouest-de-l'Île-de-Montréal

A very nice and important study on clinical feasibility and economic analysis of deploying portable MRI in remote communities. The advent of portable MRI systems can be very game-changing in providing patient care in a way that was not possible before, and understanding the implications of deploying such systems is more important than ever to really understand their benefits. #portablemri #mri #portable #health

Advancing Cardiac Arrest Management: Insights from the Frontal EEG Observational Study with BIS Advance An observational study from the Medical University of Graz is reshaping the approach to cardiac arrest management (https://lnkd.in/dXkJBNuM). This research goes beyond the traditional goal of return of spontaneous circulation (ROSC).  Despite low survival rates with good neurologic outcomes at discharge following OHCA in Europe, this study investigates using frontal EEG and bispectral index (BIS) monitoring to predict quality neurological outcomes potentially.   This pilot study evaluates 40 patients in CPR to assess the feasibility of this measurement as a first stage. Consequently, these insights could improve treatment protocols to increase survival rates with favourable neurological outcomes for OHCA survivors.   A livestream will present ongoing research projects at the physician response unit of the Medical University of Graz, including this observational study on EEG and BIS monitoring in cardiac arrest patients. The live stream is free and accessible on YouTube at (https://lnkd.in/dQwyi_vA) Join the presentation from Dr. Eichinger and Dr. Zoidl at 7:00 PM on March 12th for an informative session.   Take advantage of this opportunity to stay at the forefront of medical research and practice. #BISADVANCE #pEEG #ROSC #cardiacarrest #OHCA

Next Thursday (25 January) Karolien Baldewijns will defend the thesis ‘From guideline to practise: The organisation of multidisciplinary heart failure care in three European regions’ at 10.00h @ @MaastrichtUniversity. ➡️ Heart failure is a common, chronic and debilitating condition. To reduce the impact of heart failure, the European Society of Cardiology (ESC) has developed guidelines for the diagnosis and treatment of heart failure. This thesis examines the application of these guidelines in three European regions; Maastricht (Netherlands), Noorderkempen (Belgium) and Aachen (Germany). More specifically, it focuses on how the guidelines related to multidisciplinary care and patient education are applied and used. The overall aim of this thesis is therefore to gain a better understanding of the current organisation and regulation of heart failure care in these three regions. First, the current processes of heart failure care were explored. After which, the local implementation of European guidelines regarding multidisciplinary care and patient education was examined. Next, the extent to which national training programmes for heart failure nurses correspond to the European training programme was examined. Finally, patient education as experienced by different professionals was mapped. Supervisor: Prof. Hans-Peter Brunner-La Rocca Co-supervisors: Dr JJJ Boyne Dr A Devillé (Thomas More University of Applied Sciences) #carimmaastricht #maastrichtuniversity #phdlife #phddefence 📺 https://lnkd.in/eN8TK8JF 📖 https://lnkd.in/eQySBwnd

Major accomplishment in the management of HFPEF, with first ever 1A recommendation - made possible by a major effort to demonstrate the multiple benefits of SGLT2I in clinical trials over the past decade

First patient enrolled! The CHRU de Nancy, in collaboration with the GIE Nancyclotep clinical research team and the Institut de Cancérologie de Lorraine - ICL medical team, has enrolled its 1st patient in the international multicenter Phase I (first-in-man) study "DEBIO 0228-101": a non-randomized Phase I study evaluating the safety, tolerance and imaging characteristics of 68Ga-DPI-4452 in patients with unresectable locally advanced or metastatic solid tumors. This is the first patient in Europe to be enrolled in the study, which constitutes a major step forward in the use of theranostics in this type of pathology. Find out more about the study here: https://lnkd.in/e64g3sky #Nancyclotep #clinicaltrial #theranostics #Debiopharm #clinicalresearch #oncology

🔥Hot off the press🔥 Read our new study about valve-in-valve #TAVI #TAVR with #BEV vs #SEV just published in The American Journal of Cardiology 🔗Link: https://lnkd.in/ehutPBdp 💥Take-🏠 message: We found no difference in terms of all-cause death in ViV-TAVI with SEV versus BEV. Randomized controlled trials are warranted to validate these results. 💥My personal take: ViV-TAVI is highly influenced by the size of the valve implanted at the index #SAVR. We should keep in mind this aspect when choosing a valve for ViV-TAVI. Delivering the best indexed EOA (considering EOA, BSA and BMI) will probably make a difference in the final gradients and clinical outcomes. 💥The late outcomes of the #LYTEN trial (NCT03520101) may shed some light on this issue in the near future. 💥Nice collaboration with Xander J. Matheus Simonato Danial Ahmad James Brown Derek Serna-Gallegos Marie-Annick Clavel Philippe Pibarot Danny Dvir Ibrahim Sultan #StructuralHeart🫀 #AorticValve UPMC Heart and Vascular Institute UPMC Presbyterian Shadyside Hospital University of Pittsburgh Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval Université Laval Yale University School of Medicine The Hebrew University of Jerusalem Shaare Zedek Medical Center, Jerusalem

#Innovation | 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝘃𝗲 𝗗𝗲𝘃𝗶𝗰𝗲 𝘁𝗼 𝗧𝗿𝗲𝗮𝘁 𝗟𝘆𝗺𝗽𝗵𝗲𝗱𝗲𝗺𝗮: 𝗣𝗿𝗼𝗺𝗶𝘀𝗶𝗻𝗴 𝗥𝗲𝘀𝘂𝗹𝘁𝘀 𝗶𝗻 𝗣𝗿𝗲𝗹𝗶𝗺𝗶𝗻𝗮𝗿𝘆 𝗦𝘁𝘂𝗱𝘆 | At CHUV | Lausanne university hospital, led by Professor Lucia Mazzolai, a new study evaluating a pioneering device designed to treat and relieve lymphedema is underway. This implantable device, acting as an artificial drain for damaged or missing lymphatic vessels and driven by an external pump, yields highly encouraging results in its preliminary phase. The device, employed by CHUV’s Heart and Vessels Department, utilizes a mini-invasive technique to reduce surgical risks and foster speedy recovery. Preliminary results of this groundbreaking study were presented at the European Vascular Medicine Congress in Milan recently. This is a huge leap towards improving quality of life for cancer survivors struggling with lymphedema, as the innovative device aids in the reduction of limb swelling. 👉 Learn more >> https://lnkd.in/gTgZ_yuQ 🇨🇭 Follow #ScienceSwitzerland for the latest news and emerging trends on Swiss science, technology, education, and innovation >> www.swissinnovation.org Follow us >> Science-Switzerland #Science | #Education | #Research | #Innovation

📢 Original Research-Vol. 25 No. 5 💕 Title: Coronary Artery Plaque Phenotype and 5-Year Clinical Outcomes in Older Patients with Non-ST Elevation Acute Coronary Syndrome 🤵 Authors: Francesca Rubino, Salvatore Brugaletta, Greg Mills, Graziella Pompei, Roberto Scarsini, Flavio Ribichini, Lorenz Räber, MD, PhD , Professor Vijay Kunadian,* 🔔 Full Text: https://lnkd.in/gyNGCFC9 🔑 Keywords: virtual-histology intravascular ultrasound; non-ST elevation acute coronary syndrome; major adverse cardiovascular events; minimal lumen area; plaque burden; thin-cap fibroatheroma; older patients; 😎Welcome to your reading! #Cardiovascular #HeartHealth #CVD #HeartDisease #HealthyHeart #HeartCare #HeartAwareness #StrokePrevention #HeartAttack #Cardiology #HeartFailure #HeartResearch #BloodPressure #Cholesterol #Atherosclerosis #HeartRisk #HeartAwarenessMonth #HeartMonth #PreventHeartDisease #HealthyLifestyle #PediatricCardiology #CardiacHealth #RareDisease #CardiacTumors #MedicalResearch #HealthcareAwareness #HeartHealth #PediatricHealth #Cardiology #HeartDisease #TumorResearch #MedicalScience #CardiovascularHealth

SurgEase Innovations Ltd have some rather BIG NEWS! University Hospitals Sussex NHS Foundation Trust in partnership with Surrey Heartlands Health and Care Partnership have won the NHS England Community Diagnostic Centre Development Fund bid to trial LumenEye across the South East of England. The proposed evidence-based pathway will ensure that patients referred on the Lower Gastrointestinal Cancer Pathway with only rectal bleeding and anal symptoms and a FIT score below 40 can be referred for a digital rectoscopy examination. If they have no other symptoms, are not anaemic and have a normal abdominal and digital rectal examination they can be discharged safely from the pathway. Intermediate risk patients with a FIT between 40-80 can be referred for a CT colonography with LumenEye examination to visualise the rectum. This represents the largest co-ordinated trial of digital rectoscopy in the NHS to date with over 70% of current referrals being potentially eligible. The projected savings, release of formal endoscopy capacity and workflow efficiencies are immense and we look forward to sharing the real-world outcomes as they emerge. NHS England The Association of Coloproctology of Great Britain and Ireland (ACPGBI) Royal College of Surgeons in Ireland (RCSI) Royal College of Nursing - Company Royal College of General Practitioners #innovation #endoscopy #changemanagement #nhs #FIT